Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:48 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1129–1152 of 1,165 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Sham-device Clear all

Conditions: Alcohol Use Disorder, Alcohol Abuse, Alcoholism, Drinking Behavior, Drinking Problem
Interventions: Active Transcranial Magnetic Simulation, Sham; Device
Lead sponsor: VA Palo Alto Health Care System; Federal
Eligibility: 25 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Attention, Visual Perceptual Weakness, Social Behavior, Fluency Disorder, EEG With Periodic Abnormalities
Interventions: tDCS or Transcranial Direct Current Stimulation, Risperidone, Sham tDCS; Device · Drug · Other
Lead sponsor: Spanish Foundation for Neurometrics Development; Other
Eligibility: 6 Years to 11 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Healthy Women
Interventions: Transcranial Magnetic Stimulation Active, Transcranial Magnetic Stimulation Sham; Device
Lead sponsor: The City College of New York; Other
Eligibility: 22 Years to 40 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Opioid Withdrawal, Analgesia
Interventions: transcutaneous Auricular neurostimulation - Active, transcutaneous auricular neurostimulation - Sham; Device
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Osteo Arthritis Knee
Interventions: Long duration ultrasound; Device
Lead sponsor: ZetrOZ, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Stamford, Connecticut • Dryden, New York

Conditions: Migraine
Interventions: Cranial Electrostimulator, Sham Device; Device
Lead sponsor: University of Toledo Health Science Campus; Other
Eligibility: 18 Years to 65 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Toledo, Ohio

Conditions: Vestibular Migraine, Migraine Associated Vertigo
Interventions: Otoband Experimental, Otoband Sham; Device
Lead sponsor: Otolith Labs; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Psoriasis
Interventions: Acitretin 25Mg Oral Capsule, Excimer laser, Tazarotene 0.1% Gel,Top, Sham excimer laser; Drug · Device
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Ankle Sprains, Musculoskeletal Injury
Interventions: Transcranial Direct Current Stimulation, Sham Transcranial Direct Current Stimulation, Physical Therapy; Other
Lead sponsor: Keller Army Community Hospital; Federal
Eligibility: 18 Years to 40 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: West Point, New York

Conditions: Rhinitis, Allergic, Seasonal
Interventions: C-1266-7, C-1266-6 (placebo); Device
Lead sponsor: McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Spinal Cord Injuries
Interventions: Upper extremity training/Armeo Spring; Combination Product
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 75 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetic Foot Ulcers
Interventions: Electrohydraulic-generated shock wave, Sham device plus standard of care; Device
Lead sponsor: SANUWAVE, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 18
States / cities: Phoenix, Arizona • Tucson, Arizona • Long Beach, California + 12 more

Conditions: Retinitis Pigmentosa
Interventions: Transcorneal Electrical Stimulation using Okustim device; Device
Lead sponsor: Wills Eye; Other
Eligibility: 22 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Peripheral Artery Disease, Peripheral Vascular Disease, Aging, Walking, Difficulty
Interventions: Far red light therapy, Sham light therapy, Home-based walking exercise; Device · Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 50 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Tendon Injuries, Musculoskeletal Pain
Interventions: Therapeutic ultrasound, Placebo therapeutic ultrasound; Device
Lead sponsor: ZetrOZ, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Milford, Connecticut • Trumbull, Connecticut

Conditions: Heart Failure
Interventions: Alleviant ALV1 System, Sham-Control; Device · Other
Lead sponsor: Alleviant Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 40
States / cities: Los Angeles, California • Sacramento, California • San Diego, California + 31 more

Conditions: Chronic Pain
Interventions: Low Intensity Focused Ultrasound; Device
Lead sponsor: Virginia Polytechnic Institute and State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Pain, Procedural Pain, Local Anesthesia, Mohs Surgery, Skin Cancer
Interventions: Active Vibration:TENS, Sham TENS; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 3
States / cities: Maple Grove, Minnesota • Minneapolis, Minnesota • Wyoming, Minnesota

Conditions: Viral Infection
Interventions: Active classroom HEPA cleaner, Sham classroom HEPA cleaner; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 6 Years to 90 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Dysexecutive Syndrome, Post-Acute Sequelae of COVID-19
Interventions: Active tDCS, Sham tDCS; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Chronic Kidney Diseases
Interventions: Mindfulness-based stress reduction (MBSR), Health enhancement program (HEP), Transcutaneous Vagus Nerve Stimulation (tVNS), Sham-transcutaneous Vagus Nerve Stimulation (tVNS); Behavioral · Device
Lead sponsor: Emory University; Other
Eligibility: 40 Years to 80 Years
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Post Traumatic Stress Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS), Cognitive Processing Therapy, Repetitive Transcranial Magnet Stimulation (rTMS); Device · Behavioral
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 18 Years to 60 Years
Enrollment: 103 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Bipolar Disorder, Bipolar and Related Disorders, Veterans, Suicide, Suicidal Ideation, Mental Disorders
Interventions: Soterix 1x1 tES mini-CT; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years and older
Enrollment: 138 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Migraine
Interventions: Verum Cefaly® Abortive Program device, Sham Cefaly® Abortive Program device; Device
Lead sponsor: Cefaly Technology; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 607 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 10
States / cities: Tempe, Arizona • Encino, California • New Haven, Connecticut + 7 more

Search by objective public record fields.

Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder

Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders

TMS-Induced LH Response in Healthy Women in Luteal Phase

Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain

Long-Duration Ultrasound for Knee Osteoarthritis

Cranial Electrotherapy Stimulation in the Treatment of Migraine Headaches

SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines

Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis

Effectiveness of Transcranial Direct Current Stimulation (tDCS).

Study of a Topical Nasal Spray to Ease the Symptoms of Hayfever

Effect of a Novel Intervention Using Daily Intermittent Hypoxia and High Intensity Training on Upper Limb Function in Individuals With Spinal Cord Injury

A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers

Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy Multicenter Study

ENhancing Exercise With LIGHT to Improve Functioning in PAD

Long Duration Therapeutic Ultrasound on Tendon Injuries

Alleviant ALLAY-HFrEF Study

Investigation of Low-intensity Focused Ultrasound for Human Pain Management

E-MOHS Trial of TENS and Vibration During Local Anesthesia

School Inner City Air Study

Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)

Mindfulness in Chronic Kidney Disease

Novel Treatment of Emotional Dysfunction in Post Traumatic Stress Disorder (PTSD)

Targeted Alternating Current and Cognitive Training Intervention for Cognitive Control in Bipolar Disorders

A Phase III Trial of e-TNS for the Acute Treatment of Migraine